1.Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets
Dae-Hee KIM ; In-Jeong CHO ; Woohyeun KIM ; Chan Joo LEE ; Hyeon-Chang KIM ; Jeong-Hun SHIN ; Si-Hyuck KANG ; Mi-Hyang JUNG ; Chang Hee KWON ; Ju-Hee LEE ; Hack Lyoung KIM ; Hyue Mee KIM ; Iksung CHO ; Dae Ryong KANG ; Hae-Young LEE ; Wook-Jin CHUNG ; Kwang Il KIM ; Eun Joo CHO ; Il-Suk SOHN ; Sungha PARK ; Jinho SHIN ; Sung Kee RYU ; Seok-Min KANG ; Wook Bum PYUN ; Myeong-Chan CHO ; Ju Han KIM ; Jun Hyeok LEE ; Sang-Hyun IHM ; Ki-Chul SUNG
Korean Circulation Journal 2022;52(6):460-474
Background and Objectives:
This study aimed to investigate the association between cardiovascular events and 2 different levels of elevated on-treatment diastolic blood pressures (DBP) in the presence of achieved systolic blood pressure targets (SBP).
Methods:
A nation-wide population-based cohort study comprised 237,592 patients with hypertension treated. The primary endpoint was a composite of cardiovascular death, myocardial infarction, and stroke. Elevated DBP was defined according to the Seventh Report of Joint National Committee (JNC7; SBP <140 mmHg, DBP ≥90 mmHg) or to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) definitions (SBP <130 mmHg, DBP ≥80 mmHg).
Results:
During a median follow-up of 9 years, elevated on-treatment DBP by the JNC7 definition was associated with an increased risk of the occurrence of primary endpoint compared with achieved both SBP and DBP (adjusted hazard ratio [aHR], 1.14; 95% confidence interval [CI], 1.05–1.24) but not in those by the 2017 ACC/AHA definition. Elevated ontreatment DBP by the JNC7 definition was associated with a higher risk of cardiovascular mortality (aHR, 1.42; 95% CI, 1.18–1.70) and stroke (aHR, 1.19; 95% CI, 1.08–1.30). Elevated on-treatment DBP by the 2017 ACC/AHA definition was only associated with stroke (aHR, 1.10;95% CI, 1.04–1.16). Similar results were seen in the propensity-score-matched cohort.
Conclusion
Elevated on-treatment DBP by the JNC7 definition was associated a high risk of major cardiovascular events, while elevated DBP by the 2017 ACC/AHA definition was only associated with a higher risk of stroke. The result of study can provide evidence of DBP targets in subjects who achieved SBP targets.
2.Relationships between Thigh and Waist Circumference, Hemoglobin Glycation Index, and Carotid Plaque in Patients with Type 2 Diabetes
Myung Ki YOON ; Jun Goo KANG ; Seong Jin LEE ; Sung-Hee IHM ; Kap Bum HUH ; Chul Sik KIM
Endocrinology and Metabolism 2020;35(2):319-328
Background:
This study investigated the relationships of thigh and waist circumference with the hemoglobin glycation index (HGI) and carotid atherosclerosis in patients with type 2 diabetes.
Methods:
This observational study included 3,075 Korean patients with type 2 diabetes, in whom anthropometric measurements and carotid ultrasonography were conducted. HGI was defined as the measured hemoglobin A1c (HbA1c) level minus the predicted HbA1c level, which was calculated using the linear relationship between HbA1c and fasting plasma glucose levels. Carotid atherosclerosis was defined as a clearly isolated focal plaque or focal wall thickening >50% of the surrounding intima-media thickness.
Results:
The frequency of a positive HGI decreased with increasing thigh circumference in men and increased with increasing waist circumference in women after adjusting for potential confounding variables. Thigh and waist circumference had a combined augmentative effect on the likelihood of positive HGI, which was dramatically higher in patients in higher waist-to-thigh ratio quartiles (adjusted odds ratios for the highest compared to the lowest quartile: 1.595 in men and 1.570 in women). Additionally, the larger the thigh circumference, the lower the risk of carotid atherosclerosis, although in women, this relationship lacked significance after adjustment for potential confounders.
Conclusion
HGI was associated with thigh circumference in men and waist circumference in women. In addition, the combination of low thigh circumference and high waist circumference was strongly associated with a higher HGI in Korean patients with type 2 diabetes. In particular, thigh circumference was associated with carotid atherosclerosis in men. However, further longitudinal studies are warranted.
3.Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene.
Jae Won SONG ; Hyo Jeong HWANG ; Chang Min LEE ; Gun Ha PARK ; Chul Sik KIM ; Seong Jin LEE ; Sung Hee IHM
The Korean Journal of Internal Medicine 2018;33(3):638-641
No abstract available.
Hypogonadism*
;
Lutein*
;
Luteinizing Hormone*
4.Syndrome of inappropriate antidiuretic hormone secretion associated with seronegative neuromyelitis optica spectrum disorder.
Shin Ju OH ; Chun Gyoo IHM ; Tae Won LEE ; Jin Sug KIM ; Da Rae KIM ; Eun Ji PARK ; Su Woong JUNG ; Ji Hoon LEE ; Sung Hyuk HEO ; Kyung Hwan JEONG
Kidney Research and Clinical Practice 2017;36(1):100-104
The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a potential cause of hyponatremia of the central nervous system (CNS). Although SIADH has been reported to be associated with many other central nervous disorders, its association with neuromyelitis optica (NMO) or NMO spectrum disorders are rare. NMO is a demyelinating disorder characterized by optic neuritis and transverse myelitis. Aquaporin-4 (AQP4), which is the target antigen for a NMO autoantibody, is the predominant CNS water channel. However, some NMO patients show seronegative AQP4 antibody results. The spectrum of NMO has been changed, and new findings about the disease have been reported. Here, we report a case of seronegative NMO spectrum disorder associated with SIADH.
Central Nervous System
;
Demyelinating Diseases
;
Humans
;
Hyponatremia
;
Inappropriate ADH Syndrome
;
Myelitis, Transverse
;
Neuromyelitis Optica*
;
Optic Neuritis
;
Water
5.Response to comment on “Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene”.
The Korean Journal of Internal Medicine 2017;32(3):568-568
No abstract available.
Hypogonadism*
;
Lutein*
;
Luteinizing Hormone*
6.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.
Min Seok KIM ; Ju Hee LEE ; Eung Ju KIM ; Dae Gyun PARK ; Sung Ji PARK ; Jin Joo PARK ; Mi Seung SHIN ; Byung Su YOO ; Jong Chan YOUN ; Sang Eun LEE ; Sang Hyun IHM ; Se Yong JANG ; Sang Ho JO ; Jae Yeong CHO ; Hyun Jai CHO ; Seonghoon CHOI ; Jin Oh CHOI ; Seong Woo HAN ; Kyung Kuk HWANG ; Eun Seok JEON ; Myeong Chan CHO ; Shung Chull CHAE ; Dong Ju CHOI
Korean Circulation Journal 2017;47(5):555-643
The prevalence of heart failure (HF) is skyrocketing worldwide, and is closely associated with serious morbidity and mortality. In particular, HF is one of the main causes for the hospitalization and mortality in elderly individuals. Korea also has these epidemiological problems, and HF is responsible for huge socioeconomic burden. However, there has been no clinical guideline for HF management in Korea.
The present guideline provides the first set of practical guidelines for the management of HF in Korea and was developed using the guideline adaptation process while including as many data from Korean studies as possible. The scope of the present guideline includes the definition, diagnosis, and treatment of chronic HF with reduced/preserved ejection fraction of various etiologies.
Aged
;
Diagnosis*
;
Heart Failure*
;
Heart*
;
Hospitalization
;
Humans
;
Korea
;
Mortality
;
Prevalence
7.Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects.
Dae Young CHEON ; Jun Goo KANG ; Seong Jin LEE ; Sung Hee IHM ; Eun Jig LEE ; Moon Gi CHOI ; Hyung Joon YOO ; Chul Sik KIM
Yonsei Medical Journal 2017;58(2):319-325
PURPOSE: Chemerin has been suggested to be linked to insulin resistance and type 2 diabetes mellitus (T2DM). However, the relationship between visceral adiposity and chemerin levels remains unclear in subjects with T2DM. In this study, we investigated the relationship between serum chemerin levels and visceral adiposity. MATERIALS AND METHODS: This study included 102 subjects newly diagnosed with T2DM. The relationships between serum chemerin levels and clinical and biochemical parameters were examined. Multiple linear regression analysis was performed to determine the predictable factors of serum chemerin levels. RESULTS: Serum chemerin levels showed significant positive correlations with body mass index (BMI), waist circumference (WC), visceral fat thickness (VFT), insulin levels, the homeostasis model assessment of insulin resistance, and levels of triglycerides (log-transformed) and high-sensitivity C-reactive protein, while showing significant negative correlations with high-density lipoprotein cholesterol. After adjusting for BMI and WC, VFT showed a significant relationship with serum chemerin levels (r=0.222, p=0.027). Moreover, VFT was an independent predictive factor of serum chemerin levels (β=0.242, p=0.041). CONCLUSION: We demonstrated that chemerin is linked to metabolic syndrome components. Moreover, serum chemerin levels were associated significantly with obesity, especially visceral adipose tissue, in subjects with T2DM.
Adiposity*
;
Body Mass Index
;
C-Reactive Protein
;
Cholesterol
;
Diabetes Mellitus, Type 2
;
Homeostasis
;
Insulin
;
Insulin Resistance
;
Intra-Abdominal Fat
;
Linear Models
;
Lipoproteins
;
Obesity
;
Triglycerides
;
Waist Circumference*
8.Hypopituitarism Secondary to Paraclinoid Internal Carotid Artery Aneurysm.
Soo Haeng LEE ; Jae Won SONG ; Jae Yeon CHO ; Dong Suk KIM ; Young Jin RYU ; Sun Young PARK ; Sung Hee IHM
Korean Journal of Medicine 2016;91(1):66-69
Pituitary insufficiency due to a sellar aneurysm is relatively uncommon. The prevalence of this disorder was <0.2% in a large cohort of patients with panhypopituitarism. While uncommon, a vascular sellar lesion should be included as a differential diagnosis for a sellar mass resulting in hypopituitarism. We report herein a case of hypopituitarism with hyperprolactinemia secondary to a large (1.7-cm) saccular aneurysm at the left paraclinoid internal carotid artery.
Aneurysm*
;
Carotid Artery, Internal*
;
Cohort Studies
;
Diagnosis, Differential
;
Humans
;
Hyperprolactinemia
;
Hypopituitarism*
;
Prevalence
9.Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey.
Sangmo HONG ; Jun Goo KANG ; Chul Sik KIM ; Seong Jin LEE ; Cheol Young PARK ; Chang Beom LEE ; Sung Hee IHM
Diabetes & Metabolism Journal 2016;40(2):167-170
We aimed to estimate the threshold level of glycosylated hemoglobin (HbA1c) for the fasting plasma glucose of 100 and 126 mg/dL in the Korean adult population, using the 2011 Korea National Health and Nutrition Examination Survey. A total of 4,481 participants over 19 years of age without diabetic medications and conditions to influence the interpretation of HbA1c levels, such as anemia, renal insufficiency, liver cirrhosis, and cancers, were analyzed. A point-wise area under the receiver operating characteristic curve was used to estimate the optimal HbA1c cutoff value. A HbA1c threshold of 6.35% was optimal for predicting diabetes with a sensitivity of 86.9% and a specificity of 99.1%. Furthermore, the threshold of HbA1c was 5.65% for prediabetes, with a sensitivity of 69.3% and a specificity of 71%. Further prospective studies are needed to evaluate the HbA1c cutoff point for diagnosing prediabetes and diabetes in the Korean population.
Adult
;
Anemia
;
Blood Glucose
;
Diabetes Mellitus
;
Diagnosis
;
Fasting
;
Hemoglobin A
;
Hemoglobin A, Glycosylated*
;
Humans
;
Korea*
;
Liver Cirrhosis
;
Nutrition Surveys*
;
Prediabetic State*
;
Prospective Studies
;
Renal Insufficiency
;
ROC Curve
;
Sensitivity and Specificity
10.A Potential Issue with Screening Prediabetes or Diabetes Using Serum Glucose: A Delay in Diagnosis.
Jun Goo KANG ; Cheol Young PARK ; Sung Hee IHM ; Sung Woo PARK
Diabetes & Metabolism Journal 2016;40(5):414-417
The aim of this study was to compare the fasting serum glucose level with the fasting plasma glucose level for diagnosing hyperglycemic states in real-life clinical situations. Additionally, we investigated a usual delay in sample processing and how such delays can impact the diagnosis of hyperglycemic states. Among 1,254 participants who had normoglycemia or impaired fasting glucose (IFG) assessed by the fasting serum glucose level, 20.9% were newly diagnosed with diabetes based on the plasma fasting glucose level. Of the participants with normoglycemia, 62.1% and 14.2% were newly diagnosed with IFG and diabetes, respectively, according to the plasma fasting glucose level. In our clinical laboratory for performing health examinations, the time delay from blood sampling to glycemic testing averaged 78±52 minutes. These findings show that the ordinary time delay for sample processing of the serum glucose for screening hyperglycemic states may be an important reason for these diagnoses to be underestimated in Korea.
Blood Glucose*
;
Diagnosis*
;
Fasting
;
Glucose
;
Korea
;
Mass Screening*
;
Plasma
;
Prediabetic State*

Result Analysis
Print
Save
E-mail